Penserra Capital Management LLC Atara Biotherapeutics, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$14.7 - $19.89 $28,518 - $38,586	-1,940 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.99 - $17.9 $299 - $447	25 Added 1.31%	1,940 $34,000
Q2 2021 Aug 12, 2021	BUY	$12.89 - $16.58 $515 - $663	40 Added 2.13%	1,915 $29,000
Q1 2021 May 13, 2021	BUY	$14.0 - $20.72 $1,260 - $1,864	90 Added 5.04%	1,875 $26,000
Q4 2020 Feb 12, 2021	BUY	$12.67 - $26.23 $14,583 - $30,190	1,151 Added 181.55%	1,785 $35,000
Q3 2020 Nov 13, 2020	BUY	$11.92 - $15.87 $7,557 - $10,061	634 New	634 $8,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.59B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.